Gene · 3446
Papers297
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 297
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ferroptosis in Glioblastoma and Neuroblastoma: Molecular Mechanisms and Novel Therapeutic Strategies. | Curr Issues Mol Biol | 2026 | 41899419 | PubTator, text mining | PubMed |
| Essential role of hsa-miR-203a-3p in type I interferons immune homeostasis during influenza and NDV infection. | RNA Biol | 2026 | 41784292 | PubTator, text mining | PubMed |
| Fetal and Neonatal Immune Response to Congenital Cytomegalovirus (cCMV) Infection: A Systematically Conducted Scoping Review. | Viruses | 2026 | 41754585 | PubTator, text mining | PubMed |
| Elevated ferritin as a companion biomarker of myeloid-driven inflammation in RNP/Sm co-positive, treatment-resistant SLE endotype. | bioRxiv | 2026 | 41727036 | PubTator, text mining | PubMed |
| Somatic deficiency of the human E3 ubiquitin ligase CBL in leukocytes impairs B cell but not T cell development and function. | Nat Immunol | 2026 | 41540267 | PubTator, text mining | PubMed |
| Genetic Variants Specific to Critical COVID-19: Insights From Genome-Wide Association Studies and Structural Analysis. | J Med Virol | 2025 | 41268733 | PubTator, text mining | PubMed |
| Multimodal characterization of the responsiveness of eight hepatitis D virus genotype isolates to interferon-alpha treatment. | J Virol | 2025 | 40965142 | PubTator, text mining | PubMed |
| Rare genetic variants and severe COVID-19 in previously healthy admixed Latin American adults. | Sci Rep | 2025 | 40595275 | PubTator, text mining | PubMed |
| Rare Genetic Variants of NLRP12 in Admixed Latino-American Children With SARS-CoV-2-Related Multisystem Inflammatory Syndrome. | J Infect Dis | 2024 | 39328079 | PubTator, text mining | PubMed |
| Inhibition of SARS-CoV-2 infection and replication by Petasites hybridus CO2-extract (Ze 339). | Biomed Pharmacother | 2024 | 38061134 | PubTator, text mining | PubMed |
| Interferon response and profiling of interferon response genes in peripheral blood of vaccine-naive COVID-19 patients. | Front Immunol | 2023 | 38268924 | PubTator, text mining | PubMed |
| Senescence-associated secretory phenotypes in mesenchymal cells contribute to cytotoxic immune response in oral lichen planus. | Immun Ageing | 2023 | 38053160 | PubTator, text mining | PubMed |
| Genetic determinants of severe COVID-19 in young Asian and Middle Eastern patients: a case series. | Sci Rep | 2023 | 37985737 | PubTator, text mining | PubMed |
| Targeted mutations in IFNα2 improve its antiviral activity against various viruses. | mBio | 2023 | 37874130 | PubTator, text mining | PubMed |
| A second update on mapping the human genetic architecture of COVID-19. | Nature | 2023 | 37674002 | PubTator, text mining | PubMed |
| Virus-specific and shared gene expression signatures in immune cells after vaccination in response to influenza and vaccinia stimulation. | Front Immunol | 2023 | 37600811 | PubTator, text mining | PubMed |
| Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma. | BMC Cancer | 2023 | 37543576 | PubTator, text mining | PubMed |
| Breakthrough infection evokes the nasopharyngeal innate immune responses established by SARS-CoV-2-inactivated vaccine. | Front Immunol | 2023 | 37457721 | PubTator, text mining | PubMed |
| A Transcriptome Array-Based Approach Links Proteinuria and Distinct Molecular Signatures to Intrarenal Expression of Type I Interferon IFNA5 in Lupus Nephritis. | Int J Mol Sci | 2023 | 37445814 | PubTator, text mining | PubMed |
| Multidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibition. | Sci Adv | 2023 | 37379383 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3446/papers